Back to Search Start Over

miR‐4725‐3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.

Authors :
Ho, Kuo‐Hao
Chang, Cheng‐Kuei
Chen, Peng‐Hsu
Wang, Yu‐Jia
Chang, Wei‐Chiao
Chen, Ku‐Chung
Source :
Journal of Neurochemistry. Aug2018, Vol. 146 Issue 3, p269-288. 20p.
Publication Year :
2018

Abstract

Abstract: Glioblastoma multiforme is the most common brain tumor in adults. Because of its highly invasive nature, it is not easy to treat, resulting in high mortality rates. Stromal interacting molecule 1 (Stim1) plays important roles in regulating store‐operated Ca2+ entry, and controls invasion by cancer cells. However, the mechanisms and functions of Stim1 in glioma progression are still unclear. In this study, we investigated the effects of targeting Stim1 expression on glioma cell invasion. By analyzing profiles of glioblastoma multiforme patients from RNA‐sequencing data in The Cancer Genome Atlas, higher expression levels of STIM1 were correlated with the poor survival. Furthermore, signaling pathways associated with tumor malignancy, including the epithelial‐to‐mesenchymal transition (EMT), were activated in patients with high STIM1 expression according to gene set enrichment analyses. Higher Stim1 levels were found in glioma cells compared to human astrocytes, and these higher levels enhanced glioma cell invasion. Xanthohumol (XN), a prenylated flavonoid extracted from the hop plant Humulus lupulus L. (Cannabaceae), significantly reduced cell invasion through inhibiting Stim1 expression. From an micro(mi)RNA array analysis, miR‐4725‐3p was up‐regulated by XN treatment. Over‐expression of miR‐4725‐3p inhibited glioma cell invasion via directly targeting the 3′‐untranslated region of STIM1. The extracellular signal‐regulated kinase/c‐Fos pathway was also validated to participate in XN‐up‐regulated miR‐4725‐3p expression according to promoter and chromatin immunoprecipitation assays. These results emphasize that miR‐4725‐3p‐inhibited STIM1 signaling is involved in XN‐attenuated glioma cell invasion. These findings may provide insights into novel therapeutic strategies for future glioblastoma therapy and drug development. Open Data: Materials are available on https://cos.io/our-services/open-science-badges/ https://osf.io/93n6m/ [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00223042
Volume :
146
Issue :
3
Database :
Academic Search Index
Journal :
Journal of Neurochemistry
Publication Type :
Academic Journal
Accession number :
130993766
Full Text :
https://doi.org/10.1111/jnc.14459